1335. Deputy Richard Boyd Barrett asked the Minister for Health the reason the health research board does not routinely conduct or commission market surveillance to test illicit cannabis products for synthetic contaminants, despite evidence from other jurisdictions of such adulteration. [29262/25]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Richard Boyd Barrett under the heading Cannabis for Medicinal Use.
4 questions match, newest first.
1336. Deputy Richard Boyd Barrett asked the Minister for Health whether the health research board’s attribution of harms, such as those in a report (details supplied), to cannabis itself without distinguishing between natural cannabis and synthetic cannabinoid adulterants reflects a deliberate policy to generalize risks, potentially skewing public health data and perceptions. [29263/25]
1337. Deputy Richard Boyd Barrett asked the Minister for Health the steps the Government will take to ensure that public health messaging and research accurately differentiate between harms caused by cannabis and those caused by unregulated synthetic contaminants, particularly in the context of ongoing debates about cannabis legalization, to protect consumers and inform evidence-based policy. [29264/25]
1414. Deputy Richard Boyd Barrett asked the Minister for Health if the clinical review of the medical cannabis access programme has been completed; if so, if she publish the recommendations of the review; and if she will make a statement on the matter. [29565/25]